Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 300 participants.
Also called NCT07362446
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 300 participants
- Sponsor
- Nyrada Pty Ltd
- Registry
-
NCT07362446
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Australia
- Registry status
- Recruiting
Technical summary
Registry record NCT07362446. Randomized; quadruple masking; primary purpose treatment. Start 2026-07-02 (actual); primary completion 2027-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction
- Acronym
- PROTECT-MI
- Condition
- Myocardial Infarction
- Condition
- Reperfusion Injury
- Condition
- AMI
- Condition
- STEMI (ST Elevation MI)
- Intervention (Drug)
- Xolatryp
- Intervention (Drug)
- Placebo
- Lead sponsor
- Nyrada Pty Ltd
Record details
- Record id
cardio:ct-nct07362446- Content hash
2636d91d38d1f3ba314a81868708ea3f4add9e156c2ae6a3068fe48faf3a395b